-58.7%
MARA vs MRNA
+945.0%
-1,003.7%
-62.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.1% | +13.1% | -17.2% | -5.0% |
| 7D | -6.5% | +20.6% | -27.2% | -7.9% |
| 30D | -38.5% | +27.1% | -65.6% | -39.7% |
| 3M | -41.5% | +353.4% | -394.9% | -52.7% |
| 6M | -41.9% | +446.3% | -488.2% | -57.4% |
| YTD | -23.5% | +776.2% | -799.7% | -53.1% |
| 1Y | -58.7% | +987.9% | -1,046.6% | -77.3% |
| All | -58.7% | +945.0% | -1,003.7% | -77.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling